We are live on
!
Find out more
Parnassus Investments Portfolio holdings
AUM
$37.4B
1-Year Est. Return
35.42%
This Fund
S&P 500
This Quarter
Est. Return
+12.51%
1 Year Est. Return
+35.42%
3 Year Est. Return
+106.24%
5 Year Est. Return
+128.96%
10 Year Est. Return
+492.3%
AUM
$43.4B
AUM Growth
+$1.74B
(+4.2%)
Cap. Flow
-$2.16B
Cap. Flow
% of AUM
-4.99%
Top 10 Holdings %
Top 10 Hldgs %
38.55%
Holding
157
New
22
Increased
31
Reduced
95
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$483M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$311M |
| 3 |
Willis Towers Watson
WTW
|
+$106M |
| 4 |
Alcon
ALC
|
+$82.2M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$56.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$838M |
| 2 |
Microsoft
MSFT
|
+$524M |
| 3 |
Ball Corp
BALL
|
+$195M |
| 4 |
Pfizer
PFE
|
+$112M |
| 5 |
Simon Property Group
SPG
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.06% |
| 2 | Financials | 16.65% |
| 3 | Industrials | 12.24% |
| 4 | Healthcare | 11.49% |
| 5 | Consumer Discretionary | 11.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Gilead Sciences
GILD
$184B
| – | – |
-642,590
| Closed | -$72M |
|
152
Global Payments
GPN
$24.6B
| – | – |
-1,098,035
| Closed | -$108M |
|
|
HOLX
153
DELISTED
Hologic
HOLX
| – | – |
-726,871
| Closed | -$44.9M |
|
154
KeyCorp
KEY
$23.6B
| – | – |
-2,271,400
| Closed | -$36.3M |
|
|
155
Pfizer
PFE
$161B
| – | – |
-4,401,705
| Closed | -$112M |
|
156
Repligen
RGEN
$10.2B
| – | – |
-254,621
| Closed | -$32.4M |
|
|
157
Simon Property Group
SPG
$70.2B
| – | – |
-670,528
| Closed | -$111M |
|
Similar funds
ECSS
PIF
TWC
Parnassus Investments's Q2 2025 Portfolio in Review
As of Q2 2025, Parnassus Investments held 157 positions worth $43.4B, up 4.2% from $41.6B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Parnassus Investments withdrew a net $2.16B in Q2 2025, closing 9 positions and reducing 95 holdings. Its most notable exit was Pfizer, an estimated $112M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 30% a quarter earlier, followed by Financials and Industrials.
Against the trend, Parnassus Investments opened a new position in Willis Towers Watson worth $105M.
- Parnassus Investments's largest Q2 2025 buy was Willis Towers Watson: 341,414 shares worth $105M.
- Parnassus Investments added most to Danaher in Q2 2025, an estimated $483M increase.
- Parnassus Investments's biggest Q2 2025 reduction was Cigna, cutting an estimated $838M.
- Parnassus Investments fully exited Pfizer in Q2 2025, selling an estimated $112M.
- Parnassus Investments's ten largest holdings make up 39% of its $43.4B portfolio in Q2 2025.
- Parnassus Investments opened 22 new positions and closed 9 in Q2 2025.
- Parnassus Investments's portfolio value rose 4.2% quarter-over-quarter to $43.4B.
Based on Parnassus Investments's 13F filing for Q2 2025, filed 6 Aug 2025.